Evidence for the Involvement of a Pulmonary First-Pass Effect via Carboxylesterase in the Disposition of a Propranolol Ester Derivative after Intravenous Administration

The disposition kinetics of O-butyryl propranolol (butyryl-PL), a model compound containing an ester moiety, after intravenous administration was compared with that of PL in rats and beagle dogs. Rats showed only 30% conversion of butyryl-PL to PL up to 2 h after dosing, whereas dogs showed nearly complete conversion within 10 min after administration. The CLtotal of butyryl-PL in rats was 5.8 l/h/kg and that in dogs was 65.6 ± 18.6 l/h/kg, both of which were greater than hepatic blood flow. The in vivo conversion from butyryl-PL to PL in the rat could be explained on the basis of the hydrolysis characteristics in the liver and blood. The in vitro hydrolysis data and the in vivo data after intra-arterial administration clearly demonstrated that the extremely high CLtotal of butyryl-PL in dogs was dependent on first-pass hydrolysis in the lung in addition to hydrolysis at a blood flow-limited rate in the liver and kidney. The availability of butyryl-PL after passage through the lung was 50%. Furthermore, the isoform of carboxylesterase involved in the pulmonary hydrolysis of butyryl-PL in the dog was identified as D1, a CES-1 group enzyme. However, butyryl-PL was not recognized as a substrate by CES-1 family carboxylesterases, which are present at high levels in the rat lung (RH-1) and kidney (RL-1). These findings indicate that extrahepatic metabolism, especially in the lung, is important in the disposition of drugs containing an ester moiety after intravenous administration and that the substrate specificity of carboxylesterase isozyme distinguishes from others.

[1]  K. Suzuki,et al.  Purification, molecular cloning, and functional expression of dog liver microsomal acyl-CoA hydrolase: a member of the carboxylesterase multigene family. , 2001, Archives of biochemistry and biophysics.

[2]  P. Forkert,et al.  Involvement of CYP2E1 and carboxylesterase enzymes in vinyl carbamate metabolism in human lung microsomes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[3]  A. Horita,et al.  Species Differences in Stereoselective Hydrolase Activity in Intestinal Mucosa , 1998, Pharmaceutical Research.

[4]  H. Clark,et al.  Identification of a putative surfactant convertase in rat lung as a secreted serine carboxylesterase. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[5]  T. Imai,et al.  Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. , 1998, Life sciences.

[6]  T. Prueksaritanont,et al.  Analysis of metabolite kinetics by deconvolution and in vivo-in vitro correlations of metabolite formation rates: studies of fibrinogen receptor antagonist ester prodrugs. , 1997, Journal of Pharmacy and Science.

[7]  T. Imai,et al.  Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma. , 1997, Life Science.

[8]  J. Hochman,et al.  Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[9]  W. Bosron,et al.  Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein. , 1995, The Journal of pharmacology and experimental therapeutics.

[10]  B. Yan,et al.  Rat Serum Carboxylesterase , 1995, The Journal of Biological Chemistry.

[11]  M. Brady,et al.  Rat testicular carboxylesterase: cloning, cellular localization, and relationship to liver hydrolase A. , 1995, Archives of biochemistry and biophysics.

[12]  D. Petersen,et al.  Purification and characterization of two rat liver microsomal carboxylesterases (hydrolase A and B). , 1994, Archives of biochemistry and biophysics.

[13]  B. Yan,et al.  Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution, and the effects of age, sex, and xenobiotic treatment of rats. , 1994, Archives of biochemistry and biophysics.

[14]  T. Tsujita,et al.  Palmitoyl-coenzyme A hydrolyzing activity in rat kidney and its relationship to carboxylesterase. , 1993, Journal of lipid research.

[15]  T. Imai,et al.  An In‐vitro and In‐vivo Correlative Approach to the Evaluation of Ester Prodrugs to Improve Oral Delivery of Propranolol , 1993, The Journal of pharmacy and pharmacology.

[16]  P. Blain,et al.  Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. , 1993, Biochemical pharmacology.

[17]  Y. Masubuchi,et al.  Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. , 1992, Biochemical pharmacology.

[18]  L. V. van Zutphen,et al.  The use of three ferguson-plot-based calculation methods to determine the molecular mass of proteins as illustrated by molecular mass assessment of rat-plasma carboxylesterases ES-1, ES-2, and ES-14. , 1992, Analytical biochemistry.

[19]  J. Villeneuve,et al.  Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction. , 1992, Journal of pharmaceutical sciences.

[20]  H. Chapman,et al.  A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. , 1991, The Journal of biological chemistry.

[21]  F. Fonnum,et al.  Purification and characterization of carboxylesterases from rat lung. , 1991, The Biochemical journal.

[22]  M Hosokawa,et al.  Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. , 1990, Archives of biochemistry and biophysics.

[23]  T. Tsujita,et al.  Purification of rat kidney carboxylesterase and its comparison with other tissue esterases. , 1988, Journal of biochemistry.

[24]  K. Nambu,et al.  Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. , 1987, Biochemical pharmacology.

[25]  T. Satoh,et al.  Multiplicity and regulation of hepatic microsomal carboxylesterases in rats. , 1986, Molecular pharmacology.

[26]  K. Iwamoto,et al.  Dose‐dependent presystemic elimination of propranolol due to hepatic first‐pass metabolism in rats , 1985, The Journal of pharmacy and pharmacology.

[27]  B. Corrin,et al.  Propranolol uptake by dog lung: effect of pulmonary artery occlusion and shock lung. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[28]  R. Mentlein,et al.  Simultaneous purification and comparative characterization of six serine hydrolases from rat liver microsomes. , 1980, Archives of biochemistry and biophysics.

[29]  C T Dollery,et al.  CONCENTRATION OF (±)‐PROPRANOLOL IN ISOLATED, PERFUSED LUNGS OF RAT , 1976, British journal of pharmacology.

[30]  C. Dollery,et al.  Contribution of the liver to overall elimination of propranolol , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[31]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[32]  T. Imai,et al.  Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma. , 1999, Chirality.

[33]  M Hosokawa,et al.  The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.

[34]  A. Horita,et al.  Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver. , 1997, Chirality.

[35]  F. De Smet,et al.  The influence of aging on the stereoselective pharmacokinetics of propranolol in the rat. , 1992, Chirality.

[36]  E. Heymann Chapter 12 – Hydrolysis of Carboxylic Esters and Amides , 1982 .

[37]  E. Hodgson,et al.  Reviews in biochemical toxicology , 1979 .